CD8A and infection: The vaccine proved effective for human influenza challenge in a limited number of individuals, showing higher levels of influenza-specific CD8+ T cells in vaccinees, especially those displaying the HLA-A*0201 allele, compared to placebo controls correlating with reduced infection and viral shedding (Antrobus et al., 2012; Lillie et al., 2012).